These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25906505)

  • 1. Quality focus: colorectal cancer in South Dakota Roundtable seeks to improve screening rates.
    Ireland J
    S D Med; 2015 Mar; 68(3):131-2. PubMed ID: 25906505
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
    Spaeth A; Zwahlen M
    Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New fecal occult blood tests may improve adherence and mortality rates.
    Kumaravel V; Hayden SP; Hall GS; Burke CA
    Cleve Clin J Med; 2011 Aug; 78(8):515-20. PubMed ID: 21807923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of interactive voice response to improve colorectal cancer screening.
    Cohen-Cline H; Wernli KJ; Bradford SC; Boles-Hall M; Grossman DC
    Med Care; 2014 Jun; 52(6):496-9. PubMed ID: 24638119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
    Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
    Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance improvements of stool-based screening tests.
    van Dam L; Kuipers EJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality focus: State program focuses on increasing colorectal cancer screening.
    Schroeder SD
    S D Med; 2011 Mar; 64(3):103. PubMed ID: 21473521
    [No Abstract]   [Full Text] [Related]  

  • 9. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
    Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
    Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal cancer screening: a work in progress].
    Bretagne JF
    Presse Med; 2014 Nov; 43(11):1165-7. PubMed ID: 25261917
    [No Abstract]   [Full Text] [Related]  

  • 11. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.
    van Rossum LG; van Rijn AF; van Munster IP; Jansen JB; Fockens P; Laheij RJ; Dekker E
    Neth J Med; 2009 May; 67(5):182-6. PubMed ID: 19581668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening.
    Tao S; Brenner H
    Eur J Cancer Prev; 2013 Jul; 22(4):305-10. PubMed ID: 23702679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality focus: colorectal cancer prevention and detection.
    Herrick LM; Ireland J
    S D Med; 2015; Spec No():95. PubMed ID: 25985618
    [No Abstract]   [Full Text] [Related]  

  • 15. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorectal cancer screening disparities for rural minorities in the United States.
    Cole AM; Jackson JE; Doescher M
    J Prim Care Community Health; 2013 Apr; 4(2):106-11. PubMed ID: 23799717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian guidelines for colorectal cancer screening.
    Telford JJ
    Can J Gastroenterol; 2011 Sep; 25(9):479-81. PubMed ID: 21912757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Global Paradigm Shift in Screening for Colorectal Cancer.
    Young GP; Rabeneck L; Winawer SJ
    Gastroenterology; 2019 Mar; 156(4):843-851.e2. PubMed ID: 30776340
    [No Abstract]   [Full Text] [Related]  

  • 20. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.